Strategic and Commercial Product Development Partnerships
ICSD is actively forging long-term strategic partnerships with technology and health care industry leaders to develop new products that advance health care delivery. To date, more than $150 million has been committed toward these efforts.
Alcatel-Lucent, a telecommunications industry powerhouse, has played an important role in delivering innovative communications platforms, including multimedia and data infrastructures, wireless and wireline broadband access, and full network optimization.
UPMC has implemented a state-of-the-art Alcatel-Lucent converged data, video, and voice network that forms the backbone for UPMC’s current and future internal and external communications. UPMC and Alcatel-Lucent are pursuing co-development of several new technologies to improve patient access to the right care at the right time.
Center for Connected Medicine
At the Center for Connected Medicine, leaders in health care, computing, networking, and communications collaborate to develop a new health care model-one based on patient-centric care, technology, efficiency, and simplicity.
This new model of connected medicine integrates information technologies, health records, and devices to put patients at the center of health care. Around the world, health care providers continually pioneer techniques, treatments, and tools for treating disease and caring for patients. A major challenge is not only supporting large tertiary care centers and community hospitals, but integrating them too. Connecting the multiple facets of our health care system into a seamless environment offers better patient outcomes, improved professional practice, and reduced costs.
Cerner is a leading global supplier of health care information technology to hospitals and health care systems. UPMC is one of Cerner’s largest customers, and has successfully deployed a large range of Cerner applications on an enterprise-wide basis. Additionally, UPMC distributes and implements Cerner software internationally.
Cerner and UPMC have entered into a joint development agreement to create new technologies that improve the quality of health care. This includes jointly developing a state-of-the-art oncology information system that captures data and analyzes its relevancy to clinical decisions in a manner that assists physicians in selecting the most appropriate treatment, continually improves care, and collects comprehensive outcomes data. Technologies of this nature are being implemented in UPMC facilities in the United States and overseas.
D3 Radiation Planning
D3 Radiation Planning is a leader in rapidly implementing and supporting intensity-modulated radiation therapy (IMRT), and enables clinics to offer leading-edge radiotherapy through training, consultation, policies, protocols, remote treatment planning, and commissioning services. Since 2001, D3 has assisted more than 80 clinics nationally with advanced radiotherapy and has supported the treatment of more than 7,500 patients. D3’s expert physicists and physicians can assist with IMRT, gated therapies, advanced image-guided radiotherapy, and stereotactic radiosurgery. UPMC is developing further IMRT and stereotactic radiosurgery programs at its facility in Ireland.
General Electric's GE Healthcare, an industry leader in medical diagnostic imaging, dedicates its expertise to predicting, detecting, and monitoring disease. UPMC and GE Healthcare are involved in several co-development initiatives, including the formation and funding of a new startup entity, Omnyx, to develop and market digital pathology systems.
In the fields of radiology and cardiology, images are predominately captured, distributed, analyzed, and viewed electronically. By contrast, in pathology, manual processes are still the norm due to technology and cost barriers. Through Omnyx, GE and UPMC are developing new technologies to eliminate those barriers, which will improve care through computer-aided diagnosis and other methodologies, and improve operational efficiencies through automation.
IBM, a world leader in the development of information technology and systems infrastructure, has joined forces with UPMC under an eight-year, $317 million agreement to transform UPMC’s IT infrastructure to a virtualized on-demand environment. UPMC and IBM also have committed $50 million to co-develop new technologies, and are pursuing several initiatives in the IT arena domestically and internationally.
Developed by UPMC doctors, ImPACT is a user-friendly, Windows-based testing program specifically designed for the diagnosis and management of sports-related concussions. ImPACT software allows rapid, accurate assessment of an athlete’s symptoms and cognitive functioning.
ImPACT is currently the most widely used computerized concussion treatment program in the world, and is used with high school, college, and professional athletes. Every NFL and MLB team has selected ImPACT to comply with league mandates for concussion management programs. ImPACT’s cognitive database is the world’s largest. UPMC is developing plans to export ImPACT overseas along with the UPMC Sports Medicine model.
SimMedical creates health care simulation training programs and provides consulting services that improve clinical performance, reduce medical errors, and increase patient safety. SimMedical is the commercial outgrowth of simulation training conducted at the Peter M. Winter Institute for Simulation, Education and Research (WISER) at the University of Pittsburgh School of Medicine. Using computerized simulators from Laerdal Medical Corp., and software developed by UPMC and University of Pittsburgh researchers, SimMedical designs, develops, and implements simulation training tools, facilities, and programs.
TheraDoc supplies clinical decision infection management software that provides real-time surveillance, identification, guidance, and reporting technologies to hospitals. TheraDoc alerts clinicians to adverse events and changes in patient condition, selects evidence-based treatments, and helps meet mandatory reporting of hospital-acquired infections.
TheraDoc’s trigger-based alert system concurrently prompts timely interventions, and eliminates lag time between recognition and clinical action. Hospitals and medical centers in 30 states and the District of Columbia use TheraDoc technology for more than 28 million inpatients and outpatients.